receiving

The first child to receive a new experimental gene therapy for a rare neurological disorder died a few days after the dosage, said society sponsoring this trial on Wednesday. The company, Capsida Biotherapeutics, is part of a group of companies and laboratories in engineering of new viruses potentially capable of securely transporting genes deeply in […]